• Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=16020667).
  

PubMed=14720192; DOI=10.1111/j.1600-0714.2004.00157.x
Mackenzie I.C.
Growth of malignant oral epithelial stem cells after seeding into organotypical cultures of normal mucosa.
J. Oral Pathol. Med. 33:71-78(2004)

PubMed=16020667; DOI=10.1158/1535-7163.MCT-05-0081
Bauer J.A., Trask D.K., Kumar B., Los G., Castro J., Lee J.S.-J., Chen J.-Y., Wang S.-M., Bradford C.R., Carey T.E.
Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.
Mol. Cancer Ther. 4:1096-1104(2005)

PubMed=17944752; DOI=10.1111/j.1600-0714.2007.00617.x
Harper L.J., Piper K., Common J., Fortune F., Mackenzie I.C.
Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.
J. Oral Pathol. Med. 36:594-603(2007)

PubMed=20426848; DOI=10.1186/1471-2407-10-166
Harper L.J., Costea D.E., Gammon L., Fazil B., Biddle A., Mackenzie I.C.
Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance.
BMC Cancer 10:166.1-166.16(2010)